REPORT ID 537

Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Report 2017

Publish Date
04-Dec-17
Pages
119
Format
Electronic (PDF)

In this report, the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market competition by top manufacturers/players, with Commercializing Biomarkers in Therapeutic and Diagnostic Applications sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Roche
    Dako (Agilent Technologies)
    Merck
    BD
    Abbott
    Genesys Biolabs(20/20GeneSystems)
    Affymetrix
    Agendia
    ALMAC
    Arrayit
    Biocartic
    BG Medicine
    Thermo Fisher
    BGI
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Consumables
    Services
    Software
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Oncology
    Cardiology
    Neurology
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Report 2017
1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Overview
    1.1 Product Overview and Scope of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
    1.2 Classification of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Product Category
        1.2.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Consumables
        1.2.4 Services
        1.2.5 Software
    1.3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market by Application/End Users
        1.3.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Oncology
        1.3.3 Cardiology
        1.3.4 Neurology
        1.3.5 Other
    1.4 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market by Region
        1.4.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Status and Prospect (2012-2022)
        1.4.3 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Status and Prospect (2012-2022)
        1.4.4 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Status and Prospect (2012-2022)
        1.4.5 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Status and Prospect (2012-2022)
        1.4.7 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications (2012-2022)
        1.5.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2012-2022)
        1.5.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2012-2022)

2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Competition by Players/Suppliers, Type and Application
     2.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Competition by Players/Suppliers
        2.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications (Volume and Value) by Type
        2.2.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Type (2012-2017)
        2.2.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Type (2012-2017)
    2.3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications (Volume and Value) by Region
        2.3.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Region (2012-2017)
        2.3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Region (2012-2017)
    2.4 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications (Volume) by Application

3 United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications (Volume, Value and Sales Price)
    3.1 United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Value (2012-2017)
        3.1.1 United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2012-2017)
        3.1.2 United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2012-2017)
        3.1.3 United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price Trend (2012-2017)
    3.2 United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Players
    3.3 United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Type
    3.4 United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Application

4 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications (Volume, Value and Sales Price)
    4.1 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Value (2012-2017)
        4.1.1 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2012-2017)
        4.1.2 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2012-2017)
        4.1.3 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price Trend (2012-2017)
    4.2 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Players
    4.3 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Type
    4.4 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Application

5 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications (Volume, Value and Sales Price)
    5.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Value (2012-2017)
        5.1.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2012-2017)
        5.1.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price Trend (2012-2017)
    5.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Players
    5.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Type
    5.4 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Application

6 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications (Volume, Value and Sales Price)
    6.1 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Value (2012-2017)
        6.1.1 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2012-2017)
        6.1.2 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price Trend (2012-2017)
    6.2 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Players
    6.3 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Type
    6.4 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Application

7 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications (Volume, Value and Sales Price)
    7.1 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Value (2012-2017)
        7.1.1 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price Trend (2012-2017)
    7.2 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Players
    7.3 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Type
    7.4 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Application

8 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications (Volume, Value and Sales Price)
    8.1 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Value (2012-2017)
        8.1.1 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2012-2017)
        8.1.2 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2012-2017)
        8.1.3 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Price Trend (2012-2017)
    8.2 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Players
    8.3 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Type
    8.4 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume and Market Share by Application

9 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Players/Suppliers Profiles and Sales Data
    9.1 Roche
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Dako (Agilent Technologies)
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Merck
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 BD
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Abbott
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Genesys Biolabs(20/20GeneSystems)
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Genesys Biolabs(20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Affymetrix
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Agendia
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 ALMAC
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Arrayit
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2012-2017)